Armata Pharmaceuticals, Inc. (ARMP)
USD 1.95
(-2.5%)
USD 1.95
(-2.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.52 Million | 5.5 Million | 4.47 Million | 823 Thousand | - | - |
| Cost of Revenue | 33.77 Million | 892 Thousand | 20.01 Million | 14.44 Million | 1.35 Million | 1.35 Million |
| Gross Profit | -29.24 Million | 4.61 Million | -15.54 Million | -13.62 Million | -1.35 Million | -1.35 Million |
| Operating Expenses | 11.64 Million | 36.94 Million | 23.82 Million | 21.58 Million | 19.08 Million | 10.59 Million |
| Selling, General and Administrative Expenses | 11.64 Million | 7.43 Million | 8.28 Million | 7.96 Million | 9.26 Million | 5.7 Million |
| Research and Development Expenses | 33.77 Million | 35.01 Million | 20.01 Million | 14.44 Million | 9.82 Million | 4.89 Million |
| Other Expenses | -33.77 Million | -5.5 Million | -4.47 Million | -823 Thousand | -844 Thousand | 1.93 Million |
| Cost and Expenses | 45.41 Million | 36.94 Million | 23.82 Million | 21.58 Million | 19.08 Million | 10.59 Million |
| Operating Income | -40.89 Million | -36.94 Million | -23.82 Million | -21.58 Million | -19.75 Million | -12.52 Million |
| Interest Expense | 2.62 Million | 29 Thousand | 64 Thousand | 628 Thousand | 931 Thousand | - |
| Income Tax Expense | - | -29 Thousand | 64 Thousand | 634 Thousand | -454 Thousand | -328 Thousand |
| Earnings before Tax | -69.04 Million | -36.91 Million | -23.15 Million | -22.18 Million | -19.47 Million | -12.43 Million |
| Net Income | -69.04 Million | -36.88 Million | -23.21 Million | -22.81 Million | -19.02 Million | -12.11 Million |
| Earnings Per Share Basic | -1.91 | -1.08 | -0.96 | -1.39 | -2.43 | -8.90 |
| Earnings Per Share Diluted | -1.91 | -1.08 | -0.96 | -1.39 | -2.43 | -8.90 |
| Weighted Average Shares Outstanding | 36.07 Million | 34.29 Million | 24.1 Million | 16.41 Million | 7.82 Million | 1.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.07 Million | 34.29 Million | 24.1 Million | 16.41 Million | 7.82 Million | 1.36 Million |
| Gross Margin | -6.46 | 0.84 | -3.47 | -16.55 | - | - |
| EBIT Margin | -8.81 | -6.55 | -5.06 | -24.83 | - | - |
| Profit Margin | -15.25 | -6.70 | -5.19 | -27.72 | - | - |
| EBITDA | -39.91 Million | -36.05 Million | -22.65 Million | -20.43 Million | -19.75 Million | -9.54 Million |
| Earnings Before Tax Margin | -9.03 | -6.71 | -5.32 | -26.23 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 966 Thousand | 1.52 Million | 4.52 Million | 1.22 Million | 980 Thousand |
| Cost of Revenue | 315 Thousand | 317 Thousand | 293 Thousand | 972 Thousand | 221 Thousand | 200 Thousand |
| Gross Profit | -315 Thousand | 649 Thousand | 1.23 Million | 3.55 Million | 1 Million | 780 Thousand |
| Operating Expenses | 11.59 Million | 10.87 Million | 10.81 Million | 44.44 Million | 10.33 Million | 9.62 Million |
| Selling, General and Administrative Expenses | 3.12 Million | 2.86 Million | 2.88 Million | - | 3.58 Million | 2.35 Million |
| Research and Development Expenses | 8.47 Million | 8.01 Million | 7.92 Million | - | 7.97 Million | 8.25 Million |
| Other Expenses | 23.39 Million | -13.02 Million | -8.88 Million | - | -15.83 Million | 46 Thousand |
| Cost and Expenses | 11.91 Million | 11.19 Million | 11.1 Million | 45.41 Million | 10.33 Million | 9.62 Million |
| Operating Income | -11.91 Million | -10.22 Million | -9.57 Million | -40.89 Million | -10.33 Million | -9.62 Million |
| Interest Expense | 2.71 Million | 1.82 Million | 1.45 Million | 2.62 Million | 1.17 Million | - |
| Income Tax Expense | - | 273.72 Thousand | 17.77 Million | - | -14.65 Million | -6.26 Million |
| Earnings before Tax | 8.98 Million | -25.02 Million | -19.84 Million | -69.04 Million | -31.16 Million | -3.54 Million |
| Net Income | 8.98 Million | -25.02 Million | -19.84 Million | -69.04 Million | -31.16 Million | -3.54 Million |
| Earnings Per Share Basic | 0.25 | -0.69 | -0.55 | - | -0.86 | -0.10 |
| Earnings Per Share Diluted | -0.25 | -0.69 | -0.55 | - | -0.86 | -0.10 |
| Weighted Average Shares Outstanding | 36.15 Million | 36.12 Million | 36.1 Million | 36.07 Million | 36.08 Million | 36.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 58.24 Million | 36.12 Million | 36.1 Million | 36.07 Million | 36.08 Million | 36.06 Million |
| Gross Margin | - | 0.67 | 0.81 | 0.79 | 0.82 | 0.80 |
| EBIT Margin | - | -10.26 | -6.08 | - | -21.14 | -15.98 |
| Profit Margin | - | -25.90 | -12.99 | -15.25 | -25.44 | -3.62 |
| EBITDA | -11.59 Million | -9.91 Million | -9.28 Million | - | -25.9 Million | -15.66 Million |
| Earnings Before Tax Margin | - | -10.59 | -6.27 | -9.03 | -8.44 | -9.83 |
603662
RISMA
6088
ABVX
FNMAL
JPSTF